CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- 4 Grant or award Chief Operating Officer acquired 143,875 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 118,875 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 327 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 12,350 shares (option exercise)
- 4 Exercise or conversion Director acquired 20,246 shares (option exercise)
- 4 Open-market sale Director sold 2,491 shares at $99.64 ($248,203)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Shares withheld for taxes EVP, General Counsel gave up 491 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,941 shares (to pay taxes)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Grant or award Director acquired 2,383 shares (grant or award)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 523 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 3,463 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Customer Officer gave up 3,733 shares (to pay taxes)
Page 3 of 34 · 672 filings